# Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery

Study · id `cardio:ct-nct04284722` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04284722](<https://clinicaltrials.gov/study/NCT04284722>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04284722

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT04284722. Randomized; no masking; primary purpose prevention. Start 2020-02 (anticipated); primary completion 2021-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT04284722, source copy `cardio:ctgov-nct04284722-2020-02-26`, retrieved 2026-10-26)
- Planned start: 2020-02 (anticipated) (ClinicalTrials.gov record NCT04284722, source copy `cardio:ctgov-nct04284722-2020-02-26`, retrieved 2026-10-26)
- Primary completion: 2021-02 (anticipated) (ClinicalTrials.gov record NCT04284722, source copy `cardio:ctgov-nct04284722-2020-02-26`, retrieved 2026-10-26)
- Completion: 2021-04 (anticipated) (ClinicalTrials.gov record NCT04284722, source copy `cardio:ctgov-nct04284722-2020-02-26`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04284722-2020-02-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery
- Condition: Hyperglycemia
- Condition: Metformin
- Condition: Type 2 Diabetes
- Condition: Hyperlactatemia
- Intervention (Drug): Metformin Hydrochloride
- Lead sponsor: Kepler University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: a8ad6c15a4414d7fe5ee100b717dd5763ca2ef8cfc2e5e705acab69abeebed19
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
